Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Taisho claims preparation and use of two series of VEGF antagonists

Nov. 13, 2002

FDA designates Orathecin as a fast track drug

Nov. 12, 2002

ENMD-0995 receives orphan drug designation

Nov. 12, 2002

Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo

Nov. 12, 2002

New antitumor hydroxamates prepared and tested at Ono

Nov. 12, 2002

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Nov. 12, 2002

Cyclis licenses broad technology to expand ACT platform

Nov. 12, 2002

Genzyme initiates kidney cancer clinical trial with innovative vaccine

Nov. 11, 2002

Genta and Aventis initiate two clinical trials with Genasense

Nov. 11, 2002

Phase IIa results show early signs of clinical activity for GCS-100 in pancreatic cancer

Nov. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...